MODTXModus Therapeutics Holding ABMODTX info
$0.17info7.59%24h
Global rank34111
Market cap$5.98M
Change 7d-5.29%
YTD Performance-3.41%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Modus Therapeutics Holding AB (MODTX) Stock Overview

    Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. Its lead product is Sevuparin, a lipopolysaccharide to treat patients with sepsis, septic shock, and other systemic inflammation conditions, which is under Phase Ib clinical study. The company was founded in 2011 and is headquartered in Stockholm, Sweden.

    MODTX Stock Information

    Symbol
    MODTX
    Address
    Olof Palmes gata 29 IVStockholm, 11122Sweden
    Founded
    -
    Trading hours
    -
    Website
    https://www.modustx.com
    Country
    πŸ‡ΈπŸ‡ͺ Sweden
    Phone Number
    46 8 50 13 70 00

    Modus Therapeutics Holding AB (MODTX) Price Chart

    -
    Value:-

    Modus Therapeutics Holding AB Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.1665278934221482
    N/A
    Market Cap
    $5.98M
    N/A
    Shares Outstanding
    35.94M
    N/A
    Employees
    2.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org